Company Overview
Company Name
IN8bio
Address
2901 2nd Ave S, Suite 230, Birmingham, AL, 35233, United States
Website
in8bio.comApprox. Annual Revenue
$22.0M
Employees
120
Established
2020
Locations
2
About IN8bio
IN8bio is a clinical-stage biopharmaceutical company based in Birmingham, Alabama, focused on developing gamma-delta T cell therapies for solid and hematological tumors. The company's Deltex platform employs various approaches, including allogeneic, autologous, and genetically modified cells, to create novel cancer treatments with the goal of eliminating all cancer cells in patients.
Business Profile
Read from the IN8bio website on Oct 14, 2026. Hover an item to see the exact wording it came from.
About the website
- Website quality (AI-assessed)
- 8/10 · Current pipeline and trials listed; Contact and locations provided
- Footer copyright year
- 2026
IN8bio is hiring
Open roles listed on their website as of Oct 14, 2026.
- Associate Director, Analytical Development (T cell engager)
Hiring in: Management
View careers page →Recent changes
What changed on the IN8bio website and Google listing, as detected by Coldlytics on each visit.
Started advertising open roles
Associate Director, Analytical Development (T cell engager)
Estimated headcount moved from 51-100 to 101-250 employees
Coldlytics tracks changes like these across millions of businesses, so you can reach companies the moment they add a pixel, start hiring, or switch software.
Find companies by what just changed →IN8bio locations
2 Google Business Profile listings.
| Location | Google category | Reviews | Status |
|---|---|---|---|
| 2901 2nd Ave S, Suite 230, Birmingham, ALprimary | — | — | — |
| 2901 2nd Ave S Ste 230, Birmingham, AL | — | 5.0 (1) | Claimed |
Biotech & Life Sciences Companies near Birmingham, AL
Browse all Biotech & Life Sciences companies →
Frequently Asked Questions about IN8bio
Categories
Technologies Used
Social Profiles
Key Decision Makers
William Ho President